ArticleVeterinary medicine and science2025
Integrative Analysis of Dog Serum-Derived CircRNA Expression and Disease Severity, Inflammatory and Cardiac Damage Biomarkers Related to Canine Parvoviral Enteritis.
Article in Veterinary medicine and science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Animal virus-host interactions mediated by non-coding RNAs.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundThe tissue- and developmental stage-specific expression of circular RNAs (circRNAs) makes them promising disease biomarkers. CircRNAs play a crucial role in regulating inflammatory responses; however, their function in canine parvovirus (CPV) infection remains largely unexplored. HYPOTHESIS: We hypothesized that circRNAs serve as biomarkers for disease severity, inflammation and organ damage in dogs with CPV. MATERIALS AND
methodsThe study included six dogs with mild CPV, six with severe CPV and six healthy controls. Haematological and biochemical parameters were analysed from blood samples. CircRNA profiling in serum samples was conducted through high-throughput sequencing, followed by bioinformatic analysis to identify potential circRNA biomarkers. Associations between circRNAs and haematological/biochemical markers were examined.
resultsThe severe group exhibited significantly reduced leukocyte counts and elevated C-reactive protein (CRP) levels (p < 0.05). The mild group demonstrated higher levels of tumour necrosis factor-alpha (TNF-α), cardiac troponin I (cTnI) and creatine kinase myocardial band (CK-MB) (p < 0.05). Thus, the severe group experienced heightened inflammation, whereas the mild group demonstrated increased cardiac damage. Dogs with CPV expressed certain circRNAs differently (upregulated and downregulated), as revealed by gene ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) enrichment analyses. Eighteen cicRNAs were identified as potential biomarkers. Bioinformatic and correlation analysis revealed that cfa_circ_6789, cfa_circ_6793, cfa_circ_6785, cfa_circ_6798, cfa_circ_6791, cfa_circ_6794 and cfa_circ_3119 could serve as biomarkers of inflammation and disease severity. Conversely, cfa_circ_3114, cfa_circ_3118, cfa_circ_3117, cfa_circ_3113, cfa_circ_3119, cfa_circ_1571, cfa_circ_6786 and cfa_circ_6794 were linked to cardiac damage. CONCLUSIONS AND CLINICAL RELEVANCE: The identified circRNAs were actively involved in different stages of CPV infection and exhibited strong associations with disease onset and progression. They may play a key role in modulating infection pathogenesis while serving as potential biomarkers for inflammation and cardiac damage. This study is the first to investigate the role of circRNAs in CPV infection, providing novel insights into their diagnostic and prognostic potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.